| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Degradation pathway of sphingolipids including diseases 0.9404681753234552 2.588490591362903 0.0096397580389699 0.9968901061304124 0.9127986877822604 7 P06280,P07686,P06865,P16278,P17900 5 |
| Glycosaminoglycan degradation 0.9399894621890807 2.58659951458481 0.0096928176737272 0.9969878431252408 0.9127986877822604 7 P06865,Q9Y251,P15586,P54802,P16278 5 |
| Statin inhibition of cholesterol production 0.8953858160538128 2.4323099614563124 0.0150028621466193 0.9998777521423304 0.9127986877822604 6 P01130,Q8WTV0 2 |
| Regulation of wnt bcatenin signaling by small molecule compounds 0.8036224981513325 2.0540666059773263 0.0399692456019007 0.999999999972334 0.9127986877822604 6 Q07954,O14641,P49841 3 |
| Familial hyperlipidemia type 3 0.9816459443457656 2.0505075090879155 0.0403149317815434 0.9999999999776784 0.9127986877822604 3 P01130,Q8WTV0 2 |
| Pi3kaktmtor signaling pathway and therapeutic opportunities 0.8055941329500584 2.038480970745703 0.0415018559152815 0.9999999999893242 0.9127986877822604 7 P31749,P49815,P49841,Q8N122 4 |
| Allograft rejection 0.8089182398166447 2.005113690039984 0.0449508942560674 0.9999999999987546 0.9127986877822604 9 P01889,P04439 2 |
| Familial hyperlipidemia type 4 0.8552718685402741 1.99157315312728 0.0464179114504874 0.9999999999995016 0.9127986877822604 4 P01130 1 |
| Pi3kaktmtor vitd3 signaling 0.7673968718636942 1.9003758508475717 0.0573838137211506 0.9999999999999994 0.9127986877822604 6 P49815,P49841 2 |
| Striated muscle contraction pathway 0.7602195391231628 1.8458256852623145 0.0649175198478513 1.0 0.9127986877822604 7 P35609,P67936,O43707,P09493,P06753 5 |
| Metabolic pathway of ldl hdl and tg including diseases 0.9225386674374344 1.8343710991778512 0.0665989266511215 1.0 0.9127986877822604 3 Q8WTV0 1 |
| Neural crest cell migration in cancer 0.7637878902843261 1.81390942288921 0.0696916717878404 1.0 0.9127986877822604 9 Q99523,P31751,O96013 3 |
| Monoamine transport 0.8092981936630098 1.8081706009357692 0.0705799527103892 1.0 0.9127986877822604 4 O15127,P49815,Q92692 3 |
| Proteoglycan biosynthesis 0.8057646630314129 1.7939544897496515 0.0728204331114519 1.0 0.9127986877822604 4 Q9NX62 1 |
| Vitamin b12 metabolism 0.7554507427001971 1.7782171042420454 0.0753682048127581 1.0 0.9127986877822604 9 Q8WTV0,P98164 2 |
| Familial hyperlipidemia type 5 0.9043822022399556 1.7672488145331655 0.0771865678577254 1.0 0.9127986877822604 3 P01130 1 |
| Familial hyperlipidemia type 1 0.9043822022399556 1.7672488145331655 0.0771865678577254 1.0 0.9127986877822604 3 P01130 1 |
| Mapk cascade 0.7382928275044467 1.7514609534105947 0.0798665415170409 1.0 0.9127986877822604 7 Q9UHA4,Q16539,P27361,P45985,P28482,P62993 6 |
| Sarscov2 and covid19 pathway 0.7929577775960557 1.7422963002942329 0.0814566104835263 1.0 0.9127986877822604 4 Q8WTV0 1 |
| Nanoparticlemediated activation of receptor signaling 0.7341434499110857 1.7335165491162712 0.0830038986572814 1.0 0.9127986877822604 7 Q16539,P05556,P28482,P00533,Q02750,P62993 6 |
| Hostpathogen interaction of human coronaviruses apoptosis 0.7891437768937347 1.7268727716527348 0.0841905154530398 1.0 0.9127986877822604 4 P31749,Q07820 2 |
| Tgfbeta signaling in thyroid cells for epithelialmesenchymal transition 0.7677725118483346 1.7109099512458106 0.0870977373089614 1.0 0.9127986877822604 5 P19022,P08670,P27361,P31749 4 |
| Inclusion body myositis 0.8850917328518721 1.6956045650929583 0.0899607926670138 1.0 0.9127986877822604 3 P05067 1 |
| Copper homeostasis 0.7358735389333977 1.6939831773626974 0.0902684797815132 1.0 0.9127986877822604 9 P05067,Q13443,P25054,P49841 4 |
| Melatonin metabolism and effects 0.8781979695009072 1.6699256914615968 0.0949340665324265 1.0 0.9127986877822604 3 P42892 1 |
| Wntbetacatenin signaling pathway in leukemia 0.713065467582251 1.6656134909029825 0.0957904223343426 1.0 0.9127986877822604 6 P25054,P49841 2 |
| Il7 signaling pathway 0.7124778345691484 1.663048872960836 0.0963026528691171 1.0 0.9127986877822604 6 P31749,P49841,P27361,P28482 4 |
| Angiogenesis 0.7675451584246329 1.6392109796807284 0.101169327953152 1.0 0.9127986877822604 4 P31749,P19174,Q16539 3 |
| Il17 signaling pathway 0.7675451584246312 1.639210979680721 0.1011693279531535 1.0 0.9127986877822604 4 P31749,P49841,P27361 3 |
| Bile acids synthesis and enterohepatic circulation 0.7674516306425355 1.6388302616640162 0.101248614887087 1.0 0.9127986877822604 4 P01130 1 |
| Serotonin htr1 group and fos pathway 0.7156833679217359 1.6298683230679112 0.1031293298419726 1.0 0.9127986877822604 8 P04899,P16220,Q16539,P61586,P27361,P28482,Q02750 7 |
| Il9 signaling pathway 0.7021384961020145 1.617843831888448 0.105696257526219 1.0 0.9127986877822604 6 P62993,P50750,P27361,P28482 4 |
| Kallmann syndrome 0.7607396734837025 1.6114847011930784 0.1070741190727821 1.0 0.9127986877822604 4 P31749,P62993 2 |
| Epo receptor signaling 0.6928411355115681 1.5535311181541365 0.120296300980343 1.0 0.9127986877822604 7 P31749,P62993,P27361,P28482 4 |
| Aryl hydrocarbon receptor pathway wp2586 0.6896750820850341 1.5396408865597595 0.1236479133545738 1.0 0.9127986877822604 7 O00170,P00533,P07900,P28482,Q16543 5 |
| Kisspeptinkisspeptin receptor system in the ovary 0.6821073062640292 1.5298568366175576 0.1260521694082719 1.0 0.9127986877822604 6 P31751,P31749,P27361,P28482 4 |
| Neovascularisation processes 0.7361201021509289 1.5108167024379664 0.1308351580328954 1.0 0.9127986877822604 4 P31749,P27361 2 |
| T cell receptor and costimulatory signaling 0.718937774395462 1.5095233316664587 0.1311650974611882 1.0 0.9127986877822604 5 P31749,P49841 2 |
| Complement system in neuronal development and plasticity 0.710046063617032 1.4904740804282015 0.1360996267349559 1.0 0.9127986877822604 13 Q5KU26 1 |
| 15q112 copy number variation syndrome 0.7308260723128291 1.4891040306840977 0.1364599765814684 1.0 0.9127986877822604 4 Q06787,Q7L576 2 |
| Synaptic signaling pathways associated with autism spectrum disorder 0.7077606924080908 1.480586589355936 0.138716771149745 1.0 0.9127986877822604 13 P31751,P27361,Q05086,Q8N122,P49815,P31749,P49841 7 |
| Mfap5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement 0.6731873759631265 1.4671232321981504 0.1423425352856455 1.0 0.9127986877822604 7 P16220,P27361,P28482,P12814,P19174 5 |
| Nrp1triggered signaling pathways in pancreatic cancer 0.6958129422437216 1.451351370398393 0.1466820436236804 1.0 0.9127986877822604 12 O14786,P31751,P00533,P31749,O14646 5 |
| Regulatory circuits of the stat3 signaling pathway 0.6896917717914939 1.4473851511096685 0.1477890822123342 1.0 0.9127986877822604 11 Q8WTS6,P16949,Q16539,P27361,Q6R327,Q8N122,P00533 7 |
| Extracellular vesiclemediated signaling in recipient cells 0.66177937950897 1.440087580940537 0.1498426222374975 1.0 0.9127986877822604 6 P25054,P00533 2 |
| Regulation of apoptosis by parathyroid hormonerelated protein 0.7012422955172872 1.435973708485905 0.1510098227074301 1.0 0.9127986877822604 5 P31749,P49841 2 |
| Mfap5mediated ovarian cancer cell motility and invasiveness 0.7157240153982777 1.4270620475062965 0.1535620107404427 1.0 0.9127986877822604 4 P27361,P28482,P19174 3 |
| Serotonin receptor 467 and nr3c signaling 0.7157240153982773 1.4270620475062947 0.1535620107404431 1.0 0.9127986877822604 4 Q02750,P27361,P28482 3 |
| Erk pathway in huntingtons disease 0.7157240153982743 1.4270620475062832 0.1535620107404465 1.0 0.9127986877822604 4 P00533,P42858,P28482 3 |
| Cell migration and invasion through p75ntr 0.6983076498039595 1.4237536940020226 0.1545177845008738 1.0 0.9127986877822604 5 P31751,P31749,Q16512 3 |
| Cardiac progenitor differentiation 0.8090586145648319 1.410734969544657 0.1583227757287406 1.0 0.9127986877822604 3 P49841,P13591 2 |
| Cannabinoid receptor signaling 0.6551443382777447 1.410699369355762 0.1583332770189343 1.0 0.9127986877822604 6 P10644,P27361,P28482,Q16539 4 |
| Nanomaterial induced apoptosis 0.6910492997246496 1.393506417627189 0.1634667057173049 1.0 0.9127986877822604 5 O95831,P49327 2 |
| Glucocorticoid receptor pathway 0.6497019501864568 1.3865665062818129 0.1655739874429844 1.0 0.9127986877822604 6 P27105,Q13616,P07900 3 |
| Embryonic stem cell pluripotency pathways 0.685563586440074 1.384331671827045 0.1662569203926125 1.0 0.9127986877822604 13 P00533,P31751,O14641,P25054,P49841 5 |
| Pdgfrbeta pathway 0.6577022225897946 1.3756983311596864 0.1689150488389164 1.0 0.9127986877822604 8 P62993,P27361,P19174,P45985 4 |
| Insulin signaling in adipocytes normal condition 0.7002442123783665 1.3633446256671384 0.1727739240044539 1.0 0.9127986877822604 4 P31751,P62753 2 |
| Insulin signaling in adipocytes diabetic condition 0.7002442123783665 1.3633446256671384 0.1727739240044539 1.0 0.9127986877822604 4 P31751,P62753 2 |
| Transcription factors regulate mirnas related to cardiac hypertrophy 0.7938144640426021 1.3533488121138906 0.175944222106454 1.0 0.9127986877822604 3 P31751 1 |
| S1p receptor signal transduction 0.6510485399047811 1.3463384046462048 0.1781934056328378 1.0 0.9127986877822604 8 P04899,Q13510,P31751,P27361,P28482,P31749 6 |
| Cholesterol biosynthesis with skeletal dysplasias 0.6447799897681177 1.341592735154945 0.1797280830289369 1.0 0.9127986877822604 7 Q15392 1 |
| Map3k1 role in promoting and blocking gonadal determination 0.673281990521318 1.319355613020742 0.1870502536099043 1.0 0.9127986877822604 5 Q13464,P49841,P61586,P28482 4 |
| Nad metabolism 0.6885820149757476 1.3152893174379012 0.188412686953262 1.0 0.9127986877822604 4 Q8IXJ6,Q96EB6 2 |
| Regucalcin in proximal tubule epithelial kidney cells 0.6326101355004815 1.3106476983361093 0.1899768163849817 1.0 0.9127986877822604 6 P31749,P28482,Q8NE86 3 |
| Hematopoietic stem cell gene regulation by gabp alphabeta complex 0.7809046209023043 1.3047446176138888 0.1919798231386948 1.0 0.9127986877822604 3 P26358 1 |
| Photodynamic therapyinduced ap1 survival signaling 0.6463895637715662 1.303002216423815 0.1925740048758042 1.0 0.9127986877822604 9 Q07820,Q16539,P45985,P49327,P00533 5 |
| Splicing factor nova regulated synaptic proteins 0.684586924375625 1.29211239409863 0.1963182243103842 1.0 0.9127986877822604 17 Q9BY67,P19022,Q9NQX3,Q06481 4 |
| Oxidative damage response 0.6658947410972109 1.2884945703114523 0.1975738577188015 1.0 0.9127986877822604 5 P60953,O95551,P45985 3 |
| Tca cycle nutrient use and invasiveness of ovarian cancer 0.7673179396092307 1.253619614827178 0.2099802982763563 1.0 0.940964344155702 3 P00533,P27361 2 |
| Neural crest cell migration during development 0.6274101287055825 1.241873530497549 0.2142832276065922 1.0 0.9460207678039184 8 P31751,O96013,P31749,Q16512 4 |
| Hepatitis c and hepatocellular carcinoma 0.6325291280344645 1.219524737803695 0.2226450925259375 1.0 0.9473471822443212 10 P31749,P62993,P27361,Q16539 4 |
| Ccl18 signaling pathway 0.6267411004477715 1.2164022842371105 0.2238317142458188 1.0 0.9473471822443212 9 P07196,P19022,P08670,P33176 4 |
| Relationship between inflammation cox2 and egfr 0.6082523861955467 1.2022603345940115 0.2292626797402928 1.0 0.9552964698798304 6 P00533,P31751,P31749 3 |
| Egfr tyrosine kinase inhibitor resistance 0.6508788632407058 1.1898656431121386 0.2340992040331164 1.0 0.9552964698798304 15 P31751,P27361,P62753,P28482,P00533,P31749,P49841,P62993,P19174 9 |
| Glycogen synthesis and degradation 0.6546768867675755 1.184759321134792 0.2361126204776704 1.0 0.9552964698798304 16 P06737,P30154,P46976,Q14738,P49841,P0DP25 6 |
| Il6 signaling pathway 0.6366550020346807 1.1714870090010043 0.2414030766215475 1.0 0.9552964698798304 13 P27361,P45985,P28482,P31749,P49841,P62993 6 |
| Nonsmall cell lung cancer 0.6462368601367208 1.1697819644183995 0.2420887234576703 1.0 0.9552964698798304 15 P31751,P27361,P28482,P00533,P31749,P62993,P11802,P19174 8 |
| Bladder cancer 0.6368592413746379 1.167188813150148 0.2431341275896621 1.0 0.9552964698798304 5 P00533,P28482,P11802 3 |
| Hypothesized pathways in pathogenesis of cardiovascular disease 0.6353333844070161 1.1608196502035235 0.2457152500770574 1.0 0.9552964698798304 5 P27361,Q16539 2 |
| Serotonin receptor 2 and elksrfgata4 signaling 0.7374185908821824 1.141396057277021 0.2537051446815836 1.0 0.9566935811546936 3 P27361,P28482 2 |
| Complement system 0.6217061019823228 1.12811021724021 0.2592733746887092 1.0 0.9566935811546936 12 P98164 1 |
| Melanoma 0.6414923569493433 1.1279150497506003 0.2593557973576927 1.0 0.9566935811546936 16 Q9UHA4,P11802,P31751,P27361,P28482,Q16512,Q02750,P31749,P62993,P0DP25 10 |
| Nad biosynthetic pathways 0.626148994297621 1.122509046500222 0.2616460633023743 1.0 0.9566935811546936 5 Q8IXJ6,Q96EB6 2 |
| Matrix metalloproteinases 0.9195028114826874 1.109671099584143 0.267140780915192 1.0 0.9567518669287636 2 Q9UGU0 1 |
| Follicle stimulating hormone fsh signaling pathway 0.6074918438121463 1.1095798522662836 0.2671801172207404 1.0 0.9567518669287636 10 P16220,Q16539,P27361,P62753,P49815,P28482,P31749 7 |
| Mirna regulation of prostate cancer signaling pathways 0.5899203555238894 1.098360215453305 0.2720472275858687 1.0 0.9567518669287636 7 P49841,P35222,P28482,Q02750,P62993 5 |
| Mirna biogenesis 0.6334024281906967 1.0881969666916242 0.2765081635430793 1.0 0.9583788889817826 4 P62826,Q8WYQ5,Q9HAV4 3 |
| Rala downstream regulated genes 0.6180041456914335 1.0252326810520436 0.3052534112703495 1.0 0.9763187802608576 4 P60953,P11233,P63000 3 |
| Corticotropinreleasing hormone signaling pathway 0.6264754824954746 1.021722696022635 0.3069121659943992 1.0 0.9763187802608576 18 P09874,P42892,P04899,P07900,P16220,Q16539,P27361,P61586,P35222,P28482,Q02750,P31749,P49841,P19174 14 |
| Arrhythmogenic right ventricular cardiomyopathy 0.6118247252818315 1.021335141768713 0.3070956823565716 1.0 0.9763187802608576 15 P35609,P16615,P19022,O43707,P05556,P50402,Q02487,Q14126 8 |
| Apoptosisrelated network due to altered notch3 in ovarian cancer 0.6111459072186486 1.018419048140749 0.3084788537021841 1.0 0.9763187802608576 15 P05067,Q8NC51,Q13501,P08670,Q13616,Q16512,P31749 7 |
| Mechanoregulation and pathology of yaptaz via hippo and nonhippo mechanisms 0.5771765900944779 0.9985109791463552 0.3180316432656787 1.0 0.9763187802608576 9 O96013,P27348,P05556,Q16512,P35240 5 |
| Mapk pathway in congenital thyroid cancer 0.6988275552975585 0.9977859076554134 0.3183831851095622 1.0 0.9763187802608576 3 P27361 1 |
| Selenium micronutrient network 0.5938533033917516 0.9859036214403032 0.3241804096242142 1.0 0.9763187802608576 13 Q8WTV0 1 |
| Factors and pathways affecting insulinlike growth factor igf1akt signaling 0.5784077287345939 0.9824600971860212 0.3258732318720527 1.0 0.9763187802608576 10 P49770,P49841,P31749,Q8N122 4 |
| Leptininsulin signaling overlap 0.8804379994081097 0.9743403847969618 0.3298875590154653 1.0 0.9763187802608576 2 P31749 1 |
| 4hydroxytamoxifen dexamethasone and retinoic acids regulation of p27 expression 0.5650591075718358 0.9670177938223338 0.3335351385072398 1.0 0.9763187802608576 8 Q96KB5,P27361,P28482,Q02750,P31749 5 |
| Alpha 6 beta 4 signaling pathway 0.5891705989918004 0.965736147432352 0.3341762268006962 1.0 0.9763187802608576 13 P07942,Q16539,P27361,P28482,P31749,P62993 6 |
| Extracellular vesicles in the crosstalk of cardiac cells 0.6860202892391312 0.9506277646003995 0.3417933691705144 1.0 0.9937016976859834 3 P00533 1 |
| Thymic stromal lymphopoietin tslp signaling pathway 0.5777283402947567 0.9373581975555556 0.3485743360241329 1.0 0.998746909629324 12 Q16539,P27361,P62753,P28482,P31749,P07948 6 |
| Oncostatin m signaling pathway 0.6042986275997628 0.9276962349939704 0.3535651620231159 1.0 0.998746909629324 18 Q16539,P27361,P62753,Q6R327,P01130,P28482,Q02750,P31749,P62993 9 |
| Nitric oxide metabolism in cystic fibrosis 0.5939170889191776 0.927507560559504 0.3536630681340291 1.0 0.998746909629324 4 O60678,Q99873 2 |
| Bmp signaling in eyelid development 0.8641609943770358 0.9188154874649288 0.3581920902792901 1.0 0.998746909629324 2 P00533 1 |
| Interactions between loxl4 and oxidative stress pathway 0.5900820897874423 0.9120606265187664 0.3617368036677588 1.0 0.998746909629324 4 Q96EB6,Q8TAG9 2 |
| Nonhomologous end joining 0.6753551965964092 0.9116145010942908 0.3619716860547224 1.0 0.998746909629324 3 P12956 1 |
| Wnt signaling in kidney disease 0.6728833629366513 0.9026098011544458 0.3667330228971495 1.0 0.998746909629324 3 O14641,P61586 2 |
| 7oxoc and 7betahc pathways 0.5597968320381375 0.9018036326301048 0.3671611897532183 1.0 0.998746909629324 10 Q9UBM7,P61916 2 |
| Somatroph axis gh and its relationship to dietary restriction and aging 0.6722912966252204 0.9004551591314128 0.3678780780450084 1.0 0.998746909629324 3 P31749,Q96EB6 2 |
| Histone modifications 0.5543011673473883 0.8989768968843319 0.3686649666416968 1.0 0.998746909629324 9 Q8WTS6,Q01105 2 |
| Glioblastoma signaling pathways 0.6014945464796364 0.8761899923081543 0.3809267561254077 1.0 1.0 20 P31751,P27361,P31749,P45985,P49815,P28482,P00533,Q02750,P52701,P62993,P11802,P19174 12 |
| Resistin as a regulator of inflammation 0.5357989622706738 0.8607819486514776 0.3893581488132034 1.0 1.0 7 Q16539,P31751,P27361,P31749,P19174 5 |
| Aryl hydrocarbon receptor pathway wp2873 0.5355509017903445 0.8597070684776587 0.3899505373878857 1.0 1.0 7 O00170,Q16543,P00533 3 |
| Mesodermal commitment pathway 0.5877097170900601 0.8580351496136979 0.3908730546535912 1.0 1.0 18 P10644,P00492,Q16204,P42858,Q9BV73,O95071,Q8IWS0,Q9UPN3 8 |
| Heart development 0.6543445977343503 0.8355855254646525 0.4033881144734024 1.0 1.0 3 P28482 1 |
| Gaba receptor signaling 0.5333371592690641 0.8293699019236465 0.4068951273036656 1.0 1.0 8 P80404 1 |
| Netrinunc5b signaling pathway 0.5562061609145421 0.825128286059311 0.4092987623056618 1.0 1.0 13 P30154,Q16539,P61586,P27361,P28482,Q15257,P31749 7 |
| Pregnane x receptor pathway 0.5658729901907505 0.8154858523107513 0.4147942595638019 1.0 1.0 4 P07900 1 |
| 16p112 distal deletion syndrome 0.5192223476323579 0.789381306066066 0.4298891785541006 1.0 1.0 7 Q99873,P62993,P20339,Q9H2V7 4 |
| Exrna mechanism of action and biogenesis 0.6332149200710496 0.7604897951455063 0.4469618668646411 1.0 1.0 3 Q8WYQ5,Q9HAV4 2 |
| Fgfr3 signaling in chondrocyte proliferation and terminal differentiation 0.5029310028546433 0.7402205115830298 0.4591662035443862 1.0 1.0 6 P27361,P28482,Q16539 3 |
| Neural crest differentiation 0.5207574992462676 0.7357177185188482 0.4619025043585427 1.0 1.0 10 P19022,P49841 2 |
| Oxysterols derived from cholesterol 0.5083809054360253 0.7233073389081208 0.4694910849858389 1.0 1.0 8 Q9UBM7 1 |
| Congenital generalized lipodystrophy cgl 0.8029002663509942 0.7165307974286143 0.4736636579312341 1.0 1.0 2 P31751 1 |
| Wnt signaling pathway 0.53467015074998 0.7158616574232142 0.4740767760004765 1.0 1.0 14 P25054,O14641,P49815,P49841 4 |
| Tcell activation sarscov2 0.5408839174516452 0.7033758039665688 0.4818215812722246 1.0 1.0 16 Q9H1B7,P27361,Q6R327,Q8N122,P49815,P28482,P31749,P49841,P62993,P19174 10 |
| Cardiac hypertrophic response 0.5267075417894481 0.7022671249432936 0.4825125911596151 1.0 1.0 13 Q16539,P31751,P50750,P27361,P45985,P28482,P31749,P49841 8 |
| Met in type 1 papillary renal cell carcinoma 0.5533435467676787 0.6978878490966638 0.4852473339149279 1.0 1.0 19 O96013,P31751,P27361,Q14241,P60953,O43815,P28482,Q16512,Q02750,P31749,P62993,P19174 12 |
| Caloric restriction and aging 0.520997554216117 0.6943705365109207 0.4874498660812865 1.0 1.0 5 P31749,Q96EB6 2 |
| Spinal cord injury 0.5604475894536848 0.6896780020100005 0.4903967025646716 1.0 1.0 21 P11802,P14174,Q08722,P27361,P61586,O94813,P08670,P28482,P06493,P00533,O75116 11 |
| G1 to s cell cycle control 0.5860722433950581 0.6833874969188916 0.4943620185112629 1.0 1.0 27 P35244,O75419,P25205,P33993,P49642,Q07864,P14635,Q13416,Q9UBD5,P06493,P11802,O43913,P33991 13 |
| Head and neck squamous cell carcinoma 0.5491036998708783 0.680896405720009 0.4959370425505405 1.0 1.0 19 P31751,Q6R327,P62753,Q8N122,P49815,P00533,P31749,P11802 8 |
| Tnfrelated weak inducer of apoptosis tweak signaling pathway 0.506961109586832 0.678474493505894 0.4974708907794514 1.0 1.0 10 Q16539,P31751,P27361,P31749,P49841 5 |
| Fluoropyrimidine activity 0.5145628360660788 0.6715747796767143 0.5018544384821371 1.0 1.0 12 P31350,Q92820,Q9BZX2,P18074,P00374 5 |
| Wnt signaling pathway and pluripotency 0.5404658004078976 0.6646747943908515 0.5062585188288733 1.0 1.0 18 O14641,P45985,P01130,P25054,P49841 5 |
| Hair follicle development organogenesis part 2 of 3 0.5247393972440975 0.6565057846361875 0.5114987468420877 1.0 1.0 4 P05556,P13591 2 |
| Dna damage response only atm dependent 0.5512377039526907 0.6532033320289145 0.5136252024254064 1.0 1.0 21 P31751,P09429,O14641,P01130,P25054,P49841 6 |
| Nephrogenesis 0.7798165137614705 0.643948865517538 0.5196085930600898 1.0 1.0 2 O95747 1 |
| Tyrobp causal network in microglia 0.506585310767955 0.6386979489330415 0.5230194472775875 1.0 1.0 5 Q5T1M5,P61916,Q15758 3 |
| Mrna protein and metabolite inducation pathway by cyclosporin a 0.5912435979416226 0.6167715801965328 0.5373853999060543 1.0 1.0 3 P08195 1 |
| Mammary gland development pathway embryonic development stage 1 of 4 0.7685705830127285 0.6095005706454385 0.542192694620282 1.0 1.0 2 P31749 1 |
| Physicochemical features and toxicityassociated pathways 0.5482822912887289 0.6065944533540766 0.5441200821285088 1.0 1.0 23 P00533,P35080,P07196,P61586,P49841,P45985,P28482,P07197,Q16512,P25054,Q02750,P31749,P62993,O75116,P19174 15 |
| Il2 signaling pathway 0.4933915921499817 0.6047134743906568 0.5453693935772881 1.0 1.0 11 P27361,P62753,P28482,Q02750,P31749,P62993 6 |
| Sphingolipid metabolism in senescence 0.4979442976378359 0.6046109604289291 0.5454375223376733 1.0 1.0 12 P16278 1 |
| Apoptosis modulation by hsp70 0.7662030186445723 0.6023310687311981 0.5469537839165559 1.0 1.0 2 O95831 1 |
| Endoderm differentiation 0.5683070212517581 0.597904350169113 0.5499037570735645 1.0 1.0 28 P05067,Q9BV73,O95071,P25054,Q8IWS0,Q86VP6 6 |
| Hippoyap signaling pathway 0.5789931932860006 0.5765441879279833 0.5642474113076097 1.0 1.0 3 P35240 1 |
| Primary focal segmental glomerulosclerosis fsgs 0.5314661939595385 0.5765091338203374 0.5642710979186258 1.0 1.0 21 P35579,Q12965,P19022,Q27J81,O43707,P05556,P08670,Q14108,P31749,P19174 10 |
| Hair follicle development cytodifferentiation part 3 of 3 0.4607909371326883 0.5660525958588914 0.5713580268386769 1.0 1.0 6 Q02487 1 |
| Chromosomal and microsatellite instability in colorectal cancer 0.5225670571849719 0.5596618273492221 0.5757101242530509 1.0 1.0 20 P43246,P31751,P48729,P27361,P31749,P49841,P61586,P28482,P25054,P52701,P11233 11 |
| Leukocyteintrinsic hippo pathway functions 0.4591068314900077 0.5593307208952683 0.5759360328638881 1.0 1.0 6 P27348,P61586,Q16539 3 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.4979591471275553 0.5513915847512711 0.5813652681754871 1.0 1.0 15 P25054,P55209,P49841 3 |
| Inhibition of exosome biogenesis and secretion by manumycin a in crpc cells 0.466107229953875 0.5508657844683692 0.5817256840876559 1.0 1.0 8 O14964,P27361,P61020,P28482,P20339 5 |
| Translation inhibitors in chronically activated pdgfra cells 0.5183711385333243 0.5437834923531292 0.586590469732386 1.0 1.0 20 P23588,Q04637,Q16539,P31751,P27361,P62753,O43432,Q8N122,P45985,P60842,P28482,Q14240,P31749,Q53EL6 14 |
| Il3 signaling pathway 0.4861058733122979 0.5404725809975605 0.5888711651547451 1.0 1.0 13 P31946,P22681,P27361,P28482,Q02750,P31749,P62993,P07948 8 |
| Mbdnf and probdnf regulation of gaba neurotransmission 0.4634287114705859 0.5403433295812542 0.5889602819431698 1.0 1.0 8 Q13464,P61586,P19174 3 |
| Physiological and pathological hypertrophy of the heart 0.4453073544407872 0.5051054569114372 0.6134847688387755 1.0 1.0 6 P28482,Q16539 2 |
| Acute viral myocarditis 0.4806902163602944 0.5027969537429032 0.6151070356032251 1.0 1.0 14 Q9NRG0,P31749,P49841,Q04637 4 |
| Endometrial cancer 0.4786364963416507 0.4785671563664229 0.6322465881669297 1.0 1.0 15 P00533,P31751,P25054,P31749,P49841 5 |
| Purinergic signaling 0.714412548091155 0.453780103860892 0.6499871052558006 1.0 1.0 2 P04899 1 |
| Nocgmppkg mediated neuroprotection 0.4394290223549554 0.4487950275375534 0.6535795260931594 1.0 1.0 8 P35609,P07196,Q15334 3 |
| Target of rapamycin tor signaling 0.4614915773433012 0.4482460414215179 0.6539756378770751 1.0 1.0 13 P31749,P49815,Q8N122 3 |
| Prolactin signaling pathway 0.4965801315995483 0.4478597819751983 0.6542543953750424 1.0 1.0 21 P22681,Q16539,P61981,P27361,P62753,P49841,P05556,P28482,Q16512,Q02750,P31749,P62993,P63104 13 |
| Lipid metabolism pathway 0.4519339216061794 0.4457127907946796 0.6558047239802955 1.0 1.0 11 P10644,P31751,P13861,P49327,P31749 5 |
| Il5 signaling pathway 0.4554597753598399 0.4424114835330077 0.6581914706722509 1.0 1.0 12 P27361,P62753,P28482,P31749,P49841,P62993,P07948 7 |
| Pancreatic adenocarcinoma pathway 0.4975080341090881 0.4357569215603025 0.6630131019968823 1.0 1.0 22 O96013,P31751,P27361,P61586,P60953,P28482,Q16512,P00533,P31749,P11233,P11802 11 |
| Thyroid hormones production and peripheral downstream signaling effects 0.4794186861723805 0.43358253450504 0.664591619965806 1.0 1.0 18 Q16539,O60343,P62753,Q8N122,P49815,P28482,Q7LBC6,P49841,P62993 9 |
| Ranklrank signaling pathway 0.4658317478852919 0.416556499010898 0.6770028334392781 1.0 1.0 16 Q16539,P31751,P27361,P60953,Q13501,P28482,Q02750,P31749,P19174,P07948 10 |
| Rac1pak1p38mmp2 pathway 0.4688319984120681 0.4117541328037352 0.6805196433195135 1.0 1.0 17 P43246,P16949,Q16539,P27361,P05556,Q16512,P00533,P31749,P62993 9 |
| Camkk2 pathway 0.4494568006367293 0.4052065864370093 0.6853256639790877 1.0 1.0 13 O00429,P16220,P27361,Q8N122,Q13501,P28482,Q96EB6 7 |
| Mammary gland development pathway pregnancy and lactation stage 3 of 4 0.4150932269603481 0.3925816927864237 0.6946284632061148 1.0 1.0 6 P00533,P61201 2 |
| Hippo signaling regulation pathways 0.4668086824203437 0.3897577271616627 0.6967157053410498 1.0 1.0 18 P10644,P04899,P08754,P19022,P61586,P13861,P60953,P35222,P00533,P35240 10 |
| Disruption of postsynaptic signaling by cnv 0.4245556120593994 0.379447136505652 0.7043558531046945 1.0 1.0 9 P61981,Q06787,P27361,Q7L576 4 |
| Small cell lung cancer 0.4419596669276963 0.3791667207994607 0.7045640626368126 1.0 1.0 13 P31751,P07942 2 |
| Pdgf pathway 0.4503872832074338 0.3635638824429629 0.7161837012746057 1.0 1.0 16 P61586,P27361,P45985,P60953,P28482,Q16512,P62993,P19174 8 |
| Erbb signaling pathway 0.4696857821446634 0.356109629506514 0.7217584660287151 1.0 1.0 21 O96013,P31751,P27361,P49841,P45985,Q16512,P00533,P31749,P62993,P19174 10 |
| Nephrotic syndrome 0.4510441967807935 0.3514044779819972 0.7252849234065348 1.0 1.0 17 Q27J81,Q7Z4L5,Q14108 3 |
| Micrornas in cardiomyocyte hypertrophy 0.459801975017693 0.3379581152871785 0.7353947516954278 1.0 1.0 20 Q16539,P31751,P50750,P27361,P61586,P45985,P28482,Q02750,P31749,P49841,O75116,Q13144 12 |
| Breast cancer pathway 0.4895850119269734 0.3377916496231277 0.7355202030404673 1.0 1.0 27 P00533,P67870,P31751,O14641,P27361,P48729,P49841,P28482,P25054,P31749,P62993,P11802 12 |
| Cellular proteostasis 0.4308557891619656 0.3371943928969819 0.7359703638675752 1.0 1.0 4 O15212,Q99471,P61758 3 |
| Tnfalpha signaling pathway 0.4616290686353193 0.3301301611230688 0.741301614310454 1.0 1.0 21 P06737,Q6GQQ9,Q9NR28,Q9Y297,P27361,P45985,P28482,Q13200,Q13616,Q16543,P31749,P62993 12 |
| Influence of laminopathies on wnt signaling 0.4176951444683224 0.3269374619663929 0.7437151861115601 1.0 1.0 11 P25054,P49841 2 |
| Prostaglandin and leukotriene metabolism in senescence 0.6602545131695816 0.3190895324621549 0.7496586209908689 1.0 1.0 2 Q96EB6 1 |
| Hepatocyte growth factor receptor signaling 0.4039496651404049 0.3103364659770035 0.7563051032404629 1.0 1.0 9 P27361,P05556,P28482,Q16512,P62993 5 |
| Prion disease pathway 0.4038761824130288 0.3100998255258562 0.7564850449390528 1.0 1.0 9 P16220,P27361,P49711,P28482,P13591 5 |
| Folate metabolism 0.4337234329536993 0.3094532900383236 0.7569767386393327 1.0 1.0 16 Q8WTV0 1 |
| Proximal tubule transport 0.401832745783769 0.303548633350568 0.7614717905665496 1.0 1.0 9 Q9Y5K8,P08195 2 |
| Integrinmediated cell adhesion 0.4630762340382759 0.2951631411165603 0.7678692573960173 1.0 1.0 24 Q13464,O96013,P31751,P50552,P05556,P60953,P28482,Q16512,Q02750,P31749,P62993,O75116 12 |
| Mir517 relationship with arcn1 and usp1 0.6454572358686052 0.2866579129116582 0.7743742662840045 1.0 1.0 2 P48444 1 |
| Tolllike receptor signaling pathway 0.4024667125875228 0.2787409602018499 0.780443626094367 1.0 1.0 11 Q16539,P31751,P27361,P45985,P28482,P31749 6 |
| Rett syndrome causing genes 0.4151052917961084 0.2783037719009076 0.7807791808948137 1.0 1.0 14 P49770,P42858 2 |
| 3q29 copy number variation syndrome 0.414454908764303 0.276336371603039 0.7822897225716496 1.0 1.0 14 P02786,Q8NCM8 2 |
| Chemokine signaling pathway 0.4517662177033126 0.2740532048487444 0.7840437346278806 1.0 1.0 23 P04899,Q13464,P31751,P27361,P49841,Q9UBI6,P60953,P28482,Q16512,Q02750,P31749,P62993,O75116,P07948 14 |
| Nsp1 from sarscov2 inhibits translation initiation in the host cell 0.4076177509998408 0.2685573410896999 0.7882703434363558 1.0 1.0 13 Q13347,P55010 2 |
| Il1 signaling pathway 0.4113763190474833 0.2671034724305376 0.789389494083153 1.0 1.0 14 Q16539,P27361,P45985,Q13501,P28482,Q02750,P31749,P19174 8 |
| Translation factors 0.5028537053373757 0.2535355141389224 0.7998544211068053 1.0 1.0 37 P29692,P24534,O60841,P63241,P62495,Q15056,Q14240,P49770,Q14152,O75153,Q13347,Q9H074,Q13144,P23588,Q04637,O43432,P55010,Q05639,P60842 19 |
| Agerage pathway 0.4258515602592849 0.2477896758809608 0.8042971433279504 1.0 1.0 19 Q16539,P27361,P61586,P60953,P28482,P00533,Q02750,P31749,P15311 9 |
| Network map of sarscov2 signaling pathway 0.4604517115690792 0.2393768768089376 0.8108133585003361 1.0 1.0 28 P07858,Q08380,P62753,Q8N122,Q6PKG0,P06493,O95067,P31749 8 |
| P38 mapk signaling pathway 0.3884705704503144 0.2373275980302914 0.8124026534718107 1.0 1.0 11 P60953,P62993,P45985,Q16539 4 |
| Endochondral ossification 0.3798377706084477 0.236808242848509 0.8128055565548786 1.0 1.0 9 Q96QD8,P31749,Q9Y376 3 |
| Endochondral ossification with skeletal dysplasias 0.3798377706084477 0.236808242848509 0.8128055565548786 1.0 1.0 9 Q96QD8,P31749,Q9Y376 3 |
| Wnt signaling 0.4038314016784359 0.2331064777184629 0.815678724961882 1.0 1.0 15 P67870,O14641,P48729,P61586,P25054,P49841,O75116 7 |
| Interferon type i signaling pathways 0.4106464472219754 0.2287096290049048 0.8190946102790471 1.0 1.0 17 P23588,Q99873,P22681,P16220,Q16539,P62753,Q8N122,P60842,Q53EL6 9 |
| Initiation of transcription and translation elongation at the hiv1 ltr 0.3804559794349291 0.2265843089351008 0.8207469946362442 1.0 1.0 10 P50750,P18615,O94992 3 |
| Ptf1a related regulatory pathway 0.6134951168984961 0.2236897577273647 0.8229987161701424 1.0 1.0 2 P35222 1 |
| Gammaglutamyl cycle for the biosynthesis and degradation of glutathione including diseases 0.6131991713524766 0.2231534361488749 0.8234160907000747 1.0 1.0 2 P48637 1 |
| 16p112 proximal deletion syndrome 0.4452498656587526 0.2207540836927019 0.8252839174226141 1.0 1.0 26 Q9NY27,Q16204,P27361,P78318,Q6IN85,P15311 6 |
| Ampactivated protein kinase ampk signaling 0.411629974354075 0.2199551673398148 0.8259060708885404 1.0 1.0 18 P31751,Q8N122,P14635,P49815,Q9Y376,P31749 6 |
| Notch signaling pathway 0.3899860459788916 0.218044754755173 0.8273942409860826 1.0 1.0 13 Q92542,P49841 2 |
| Tgfbeta signaling pathway 0.4925999445646968 0.2152987195973104 0.8295344278346313 1.0 1.0 38 P05067,O14964,Q13464,Q16539,Q9Y297,P61586,P05556,P45985,Q01082,P60953,P28482,Q13616,P06493,O95067,P31749,P62993,Q02750 17 |
| Intraflagellar transport proteins binding to dynein 0.3625604499350678 0.2006012366202481 0.8410103910448414 1.0 1.0 8 Q8NCM8,O43237 2 |
| Epithelial to mesenchymal transition in colorectal cancer 0.4358397296029556 0.1963494034984004 0.8443366954855531 1.0 1.0 26 Q16539,Q16625,P31751,P19022,P27361,P49841,P45985,Q16512,P31749,P62993 10 |
| Myometrial relaxation and contraction pathways 0.4140575997676917 0.1935786698409894 0.8465058012559468 1.0 1.0 21 P31946,P10644,Q9Y3B8,Q04917,P16220,P19174,P16615,P61981,Q05682,P62258,P13861,Q9UBI6,P0DP25,P63104 14 |
| Burn wound healing 0.3623692764570047 0.1891039658045884 0.8500113333048258 1.0 1.0 9 P09429 1 |
| Praderwilli and angelman syndrome 0.3618593409535525 0.1877862850128469 0.8510441874763339 1.0 1.0 9 Q9UIS9,P11802,Q05086,Q7L576 4 |
| Hippomerlin signaling dysregulation 0.4075042862989261 0.1875020249618206 0.851267036155301 1.0 1.0 20 P10644,O96013,P19022,P13861,P05556,Q16512,P00533 7 |
| Osteoblast differentiation and related diseases 0.3650010970853248 0.1851427445822047 0.8531170757781097 1.0 1.0 10 P27361,Q16539 2 |
| Bdnftrkb signaling 0.3721749266929088 0.182207397463837 0.855419967835934 1.0 1.0 12 Q15334,P49815,P28482,Q02750,P31749,P62993,P19174 7 |
| Androgen receptor signaling pathway 0.4459042692553641 0.1805384120325321 0.8567299013528338 1.0 1.0 30 P16220,Q13464,P61586,Q05086,P31749,P60953,P35222,Q96EB6,P00533,Q9UNE7,Q9UBS8,P49841,O75116 13 |
| Retinoblastoma gene in cancer 0.5120757883074684 0.1737015472865246 0.8621000214531995 1.0 1.0 47 P35244,P25205,P14635,P31350,O75419,P16949,P49642,P15927,P11802,P33993,P09429,Q07864,P26358,P52701,Q9NQW6,P00374,Q16204,P26583,P06493,O95067,P33991 21 |
| Il4 signaling pathway 0.3642701516544021 0.1728576512264986 0.8627633199061644 1.0 1.0 11 Q16539,P27361,P28482,P31749,P62993 5 |
| Gastrin signaling pathway 0.4357073985040893 0.1660480527238036 0.8681191344299151 1.0 1.0 29 Q07157,Q9UHA4,Q16539,P05556,P28482,P62993,P62753,P16220,P27361,P35222,P31749,P49841,P19174,P61586,P60953,Q16512,P00533,Q02750,Q13464 19 |
| Regulation of actin cytoskeleton 0.4735954462138167 0.1595063544431423 0.8732699522919234 1.0 1.0 39 O96013,P28482,Q9NSV4,Q9UQB8,O75116,Q8TBX8,P35241,P15311,Q92888,P27361,Q9UBI6,P25054,P35580,P46940,P61586,P60953,Q16512,P00533,Q02750,Q13464 20 |
| Ebola virus infection in host 0.4890447476653418 0.157889042229876 0.8745442327913353 1.0 1.0 43 P07858,O43707,P05556,P28482,Q99816,P51151,P04439,Q00610,P27361,P01889,P10321,P31749,P20339,P61916,O15118,P46940,P61586,Q16512,P00533 19 |
| 15q133 copy number variation syndrome 0.4060419826920722 0.1498810081217209 0.8808584957701713 1.0 1.0 3 Q9BXW9 1 |
| Type ii diabetes mellitus 0.404921305071441 0.1482196922043615 0.8821693913352462 1.0 1.0 3 P28482 1 |
| Hepatitis b infection 0.4014255587717728 0.1440075590528889 0.8854945005970822 1.0 1.0 23 P31946,P16220,Q16539,P31751,P27361,P45985,O00571,P28482,P63104,P49327,Q02750,P31749,P62993,Q15904 14 |
| Ras signaling 0.4353624990727975 0.1378809249677721 0.8903345260763089 1.0 1.0 32 P20339,O96013,P31751,Q16512,P27361,P61586,Q9UBI6,P60953,P28482,P55196,P00533,P31749,P11233,P62993,P0DP25,P19174 16 |
| Cohesin complex cornelia de lange syndrome 0.3805726123189325 0.1342986987169347 0.8931663821951539 1.0 1.0 19 P30154,Q7Z5K2,Q14738,P06493,P25054 5 |
| Notch signaling 0.333888713749737 0.1311167099003469 0.8956829826900794 1.0 1.0 8 Q92542 1 |
| Microtubule cytoskeleton regulation 0.3775204497734808 0.1278012722962036 0.8983062431752065 1.0 1.0 19 P16949,Q16512,Q15691,P46821,P60953,P06493,P25054,P31749,P49841 9 |
| Integrated cancer pathway 0.3582536932502398 0.1218119132443553 0.90304797881078 1.0 1.0 15 P52701,P31749,P43246,P06493 4 |
| Pi3kakt signaling pathway 0.4717025629118155 0.1210071025283918 0.9036854095334356 1.0 1.0 43 Q07820,P31751,P05556,Q8N122,P49815,P28482,Q14738,P62993,P07942,P62753,P11802,P08238,P27361,Q9UBI6,Q16513,P31749,P49841,P30154,P23588,P07900,Q16543,Q16512,P00533,Q02750 24 |
| 1q211 copy number variation syndrome 0.3367600464255913 0.1197804459990361 0.9046570722389752 1.0 1.0 10 Q9Y624,Q16625,P55196 3 |
| Ncrnas involved in wnt signaling in hepatocellular carcinoma 0.3472801161707993 0.1161279062892476 0.907551172412755 1.0 1.0 13 O14641,P49841 2 |
| Focal adhesion pi3kaktmtorsignaling pathway 0.4682056515256629 0.1140643119711494 0.9091868124569632 1.0 1.0 43 P31751,P05556,Q8N122,P49815,P28482,O14654,Q14738,P62993,P07942,P62753,P08238,P27361,Q9UBI6,Q9Y376,P31749,P49841,P30154,P23588,P07900,Q16543,P00533,Q02750 22 |
| Fragile x syndrome 0.4839959447711744 0.1135808252207697 0.9095700882284752 1.0 1.0 47 P05067,Q06787,P10644,Q04637,Q15334,Q00610,P80404,P31749,Q8N122,Q7L576,P46821,P60842,P49815,Q9Y4R8,Q9NQX3,P62993,P19174 17 |
| Ectoderm differentiation 0.3807905231322769 0.109560134892507 0.9127582280143648 1.0 1.0 22 P16278,P26583 2 |
| Tcell antigen receptor tcr pathway during staphylococcus aureus infection 0.3519988519811384 0.109201368895421 0.9130427745826628 1.0 1.0 15 P27361,Q16512,Q02750,P31749,P49841,P62993,P11802,P19174 8 |
| G13 signaling pathway 0.3551821882130904 0.1074279711526355 0.9144494651343776 1.0 1.0 16 P46940,P61586,Q92888,Q7L576,P60953,Q16512,O75116 7 |
| Calcium regulation in cardiac cells 0.3918283939222203 0.1072430362490961 0.914596174288159 1.0 1.0 25 P31946,P10644,Q9Y3B8,Q04917,P04899,P08754,P05026,P61981,P16615,P62258,P13861,Q9UBI6,P54709,P0DP25,P63104 15 |
| Hijack of ubiquitination by sarscov2 0.3241603632478826 0.1038487785034462 0.91728935605843 1.0 1.0 4 Q13564 1 |
| Proteasome degradation 0.4577278010696077 0.1016799694773111 0.9190107017713676 1.0 1.0 42 Q99436,P04439,O43242,Q15008,P01889,Q13200,P10321,P28072,O00231 9 |
| Apoptosis modulation and signaling 0.3355596108232065 0.1011548615422641 0.9194275281270848 1.0 1.0 12 P27361,Q07820,O95831,P49327 4 |
| Ras and bradykinin pathways in covid19 0.3197749743570384 0.0979272688183965 0.9219900466641452 1.0 1.0 4 P61586,P28482 2 |
| Envelope proteins and their potential roles in edmd physiopathology 0.3490046854593606 0.0883499756489142 0.929598519393082 1.0 1.0 17 P33176,P61586,P27361,P50402,P28482,Q14739,P62993 7 |
| Unfolded protein response 0.3522794552989912 0.0872052882313656 0.9305083359722026 1.0 1.0 3 P05198,Q9Y3I0 2 |
| Metastatic brain tumor 0.3522794552989888 0.0872052882313637 0.9305083359722042 1.0 1.0 3 P60953,Q00534 2 |
| Amyotrophic lateral sclerosis als 0.3213453305988462 0.082813522407877 0.9339998167362568 1.0 1.0 11 P07196,P20339,Q16539 3 |
| Autophagy 0.3043864848844125 0.0817253473018898 0.934865121545825 1.0 1.0 7 P54619,Q96B36,Q7Z3C6,Q99570,Q8N122,P42345 6 |
| Nuclear receptors in lipid metabolism and toxicity 0.5001479727730175 0.0814130461495569 0.9351134742252744 1.0 1.0 2 P08183 1 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.3722292212336716 0.0791734722232099 0.9368946444400066 1.0 1.0 24 Q15392 1 |
| Focal adhesion 0.4285145892348827 0.078343885734179 0.9375545089491428 1.0 1.0 38 O96013,Q9Y490,P31751,O43707,P05556,P28482,P62993,O75116,P07942,P27361,P31749,P49841,P61586,P60953,Q16512,P00533,Q02750,P50552,Q13464 19 |
| Ferroptosis 0.363480253739868 0.0714603322595393 0.9430313940832884 1.0 1.0 23 P02786,Q96QD8,Q9NZ45 3 |
| H19 action rbe2f1 signaling and cdkbetacatenin activity 0.290494521764875 0.0654813862803701 0.9477907261216758 1.0 1.0 4 P35222,P11802,O75367 3 |
| Sterol regulatory elementbinding proteins srebp signaling 0.3920279767252964 0.0588840378589164 0.9530444719325052 1.0 1.0 32 Q8WTV0 1 |
| Purine metabolism 0.2935072635635903 0.0580785110140926 0.953686091221279 1.0 1.0 8 P00813,P00492,Q9BY32,P30566,P00491,P07741,P30520 7 |
| Neurodegeneration with brain iron accumulation nbia subtypes pathway 0.3050091962713966 0.0569779290496916 0.9545627766399842 1.0 1.0 11 P49815 1 |
| Folatealcohol and cancer pathway hypotheses 0.3019782247746456 0.0560701091244057 0.9552859559281544 1.0 1.0 3 P16220 1 |
| Sulfation biotransformation reaction 0.2933688573120125 0.0528111199136058 0.9578824014563156 1.0 1.0 3 O43252,P00390 2 |
| White fat cell differentiation 0.4270494229061943 0.0462608663079601 0.9631023300582509 1.0 1.0 2 P16220 1 |
| Vitamin d receptor pathway 0.294152567527458 0.0372447534595447 0.970289855247604 1.0 1.0 12 P08183,Q92604,Q92783,Q96KA5,P49427,P04080,P20020,Q96JM3,Q5VV42,P24941,P09493 11 |
| Galanin receptor pathway 0.3651968037881103 0.0360937779392355 0.9712075835821992 1.0 1.0 2 P16220 1 |
| Genes related to primary cilium development based on crispr 0.3054565191689418 0.0359494450653645 0.9713226698640752 1.0 1.0 15 Q7Z4L5,Q8NCM8 2 |
| Lncrnamediated mechanisms of therapeutic resistance 0.3521751997632512 0.0351643203598309 0.971948712853201 1.0 1.0 2 P08183 1 |
| Photodynamic therapyinduced unfolded protein response 0.279655990510085 0.0347711619394211 0.9722622161592018 1.0 1.0 9 P05198,P23381,Q9BY44,Q15084,P27797,O43776,P08243,Q13217 8 |
| Gpr143 in melanocytes and retinal pigment epithelium cells 0.3231725362533374 0.0339135686133293 0.9729460732238217 1.0 1.0 2 P16220 1 |
| Apoptosis 0.2854160421120678 0.031905699939956 0.9745472530606618 1.0 1.0 11 P31749,Q07820,P49327,P45985 4 |
| Tcell receptor tcr signaling pathway 0.3234503088285601 0.0280101901008627 0.9776540238114502 1.0 1.0 21 P16220,Q16539,Q16512,P27361,P08670,P60953,P28482,P49327,Q02750,P31749,P62993,P19174 12 |
| Adipogenesis 0.2794774755774867 0.0134967898714384 0.9892314466814388 1.0 1.0 14 P14174,Q9NZ45 2 |
| Mecp2 and associated rett syndrome 0.3176341270865923 0.0133937299954342 0.9893136691330862 1.0 1.0 23 P62753,Q05086,P67809,P49711,P31749 5 |
| Purine metabolism and related disorders 0.272565320665081 0.0112682831551353 0.9910094011065234 1.0 1.0 13 P22102,P00813,P00492,O15067,Q9BY32,P30566,P31153,P00491,P31939,P07741,Q06203,P30520 12 |
| Nongenomic actions of 125 dihydroxyvitamin d3 0.2411531344530381 0.0014011197360363 0.9988820685605556 1.0 1.0 9 P27361,Q16539 2 |
| G protein signaling pathways 0.2766773232827669 0.001114783538381 0.9991105316103186 1.0 1.0 17 P10644,P04899,Q92888,P61586,P13861,Q9UBI6,Q99996 7 |
| Common pathways underlying drug addiction 0.2305944017529608 0.0005920314809276 0.9995276272494532 1.0 1.0 7 Q02750,P27361,P28482 3 |
|
|
